Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.19.3.a.u2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Oct. 01, 2019
Mar. 31, 2019
Advertising expenses     $ 37,144 $ 40,769    
Revenue $ 169,575 $ 413,109 625,306 472,509    
Operating lease right-of-use assets, net $ 350,752   $ 350,752    
Leases [Member]            
Operating lease right-of-use assets, net         $ 372,490  
Applied Products LLC [Member]            
Owned interest entity     100.00%      
Revenue     $ 192,011 472,509    
Trace Analytics [Member]            
Owned interest entity     51.00%      
Revenue     $ 433,295    
Applied Biopharma LLC [Member] | SHL Management LLC [Member]            
Owned interest entity     100.00%      
VitaCBD LLC [Member]            
Owned interest entity     80.00%